$9.81
-0.52-5.03%
Last update: Oct 23, 7:47 PM
Zevra Therapeutics Inc (ZVRA) Stock Price, Quote, News & History
ZVRANASDAQ
Zevra Therapeutics jumped in Tuesday premarket trading after partnering with GeneDx to expand NPC genetic testing and reporting fourth-quarter earnings and...
You can purchase shares of Zevra Therapeutics (NASDAQ:ZVRA) through any online brokerage.
Other companies in Zevra Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Zevra Therapeutics has a consensus price target of $23.50.
The stock price for Zevra Therapeutics (NASDAQ: ZVRA) is $9.83 last updated October 23, 2026 at 7:47 PM EDT.
There are no upcoming dividends for Zevra Therapeutics.
Zevra Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Zevra Therapeutics.
Zevra Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Zevra Therapeutics Inc is a commercial-stage company with a late-stage pipeline committed to bringing life-changing therapeutics to people living with rare diseases. The Company is focused on expanding patient access, progressing its pipeline toward...
